Jump to navigation
For the purpose of determining whether an article containing ammonia is subject to the Federal Caustic Poison Act, the ammonia content is to be calculated as NH3.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.
This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].
It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.
§ 321 - Definitions; generally
§ 331 - Prohibited acts
§ 335 - Hearing before report of criminal violation
§ 342 - Adulterated food
§ 343 - Misbranded food
§ 348 - Food additives
§ 351 - Adulterated drugs and devices
§ 352 - Misbranded drugs and devices
§ 355 - New drugs
§ 360b - New animal drugs
§ 361 - Adulterated cosmetics
§ 371 - Regulations and hearings
§ 372 - Examinations and investigations
§ 374 - Inspection
§ 7671 - Definitions
§ 7671a - Listing of class I and class II substances
§ 7671b - Monitoring and reporting requirements
§ 7671c - Phase-out of production and consumption of class I substances
§ 7671d - Phase-out of production and consumption of class II substances
§ 7671e - Accelerated schedule
§ 7671f - Exchange authority
§ 7671g - National recycling and emission reduction program
§ 7671h - Servicing of motor vehicle air conditioners
§ 7671i - Nonessential products containing chlorofluorocarbons
§ 7671j - Labeling
§ 7671k - Safe alternatives policy
§ 7671l - Federal procurement
§ 7671m - Relationship to other laws
§ 7671n - Authority of Administrator
§ 7671o - Transfers among Parties to Montreal Protocol
§ 7671p - International cooperation
§ 7671q - Miscellaneous provisions
Title 21 published on 2015-04-01
The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 21 CFR Part 2 after this date.
The Food and Drug Administration (FDA or Agency) is seeking public comment on whether the uses of ozone-depleting substances (ODSs), including chlorofluorocarbons (CFCs), in certain FDA-regulated products currently designated essential are no longer essential under the Clean Air Act due to the availability of alternatives that do not use CFCs or because the products are no longer being marketed. Essential-use products are exempt from FDA's ban on the use of CFC propellants in FDA-regulated products and the Environmental Protection Agency's (EPA's) ban on the use of CFCs in pressurized dispensers. FDA is seeking public comment because it is responsible for determining which FDA-regulated products that release CFCs or other ODSs are essential uses under the Clean Air Act. FDA is soliciting comments to assist the Agency in striking an appropriate balance that will best protect the public health, both by ensuring the availability of an adequate number of alternatives and by curtailing the release of ODSs.